Star Equity Holdings Inc Revenue Growth Rates (STRR), Current and Historic Growth - CSIMarket
CSIMarket
 


Star Equity Holdings Inc   (NASDAQ: STRR)
 

STRR's Revenue Growth by Quarter and Year

Star Equity Holdings Inc 's Revenue results by quarter and year




STRR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 50.06
FY 50.06

STRRs Annual Revenue
Star Equity Holdings Inc 's Revenue in the fiscal year 2025 $ 172.16 millions
Star Equity Holdings Inc 's Revenue in the fiscal year 2024 $ 53.36 millions
Star Equity Holdings Inc 's Revenue in the fiscal year 2023 $ 45.79 millions
Star Equity Holdings Inc 's Revenue in the fiscal year 2022 $ 112.15 millions
Star Equity Holdings Inc 's Revenue in the fiscal year 2021 $ 106.56 millions




STRR Revenue first quarter 2026 Y/Y Growth Comment
Star Equity Holdings Inc achieved in the first quarter 2026, above Company average Revenue surge of 287.47% year on year, to $ 50.06 millions.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 70 other companies have achieved higher Revenue growth. While Star Equity Holdings Inc ' s Revenue doubling of 287.47% ranks overall at the positon no. 1281 in the first quarter 2026.




STRR Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - 232.11 % 21.19 % -56.1 %
3rd Quarter September - 251.1 % 30.84 % -6.03 %
2nd Quarter June - 75.89 % 51.63 % -47.11 %
1st Quarter March 287.47 % 41.67 % -26.15 % -50.7 %
FY   - 164.96 % 16.53 % -

Financial Statements
Star Equity Holdings Inc 's first quarter 2026 Revenue $ 50.06 millions STRR's Income Statement
Star Equity Holdings Inc 's first quarter 2025 Revenue $ 12.92 millions Quarterly STRR's Income Statement


STRR Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 18.41 % 25.18 % 35.15 %
3rd Quarter September - 102.28 % 1.34 % 17.44 %
2nd Quarter June - 83.51 % 47.81 % -28.02 %
1st Quarter March -11.85 % -24.44 % -35.36 % -61.57 %
FY (Year on Year)   - 164.96 % 16.53 % -




Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #71
Healthcare Sector #204
Overall #1281

Revenue Y/Y Growth Statistics
High Average Low
295.31 % 31.62 % -74.12 %
(March 31, 2016)   (Mar 31 2024)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #71
Healthcare Sector #204
Overall #1281
Revenue Y/Y Growth Statistics
High Average Low
295.31 % 31.62 % -74.12 %
(March 31, 2016)   (Mar 31 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Star Equity Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1112.5 % 27.17 % -92.79 %
(Mar 31 2024)  


STRR's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Star Equity Holdings Inc disclosed drop in Revenue from the fourth quarter by -11.85% to $ 50.06 millions, from $ 56.79 millions achived in the previous reporting period.

But that's not important problem, as Star Equity Holdings Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 112 other companies have achieved higher Revenue quarter on quarter growth. While Star Equity Holdings Inc 's Revenue growth quarter on quarter, overall rank is 2619.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #113
Healthcare Sector #355
Overall #2619
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #113
Healthcare Sector #355
Overall #2619
Revenue Q/Q Growth Statistics
High Average Low
1112.5 % 27.17 % -92.79 %
(Mar 31 2024)  


STRR's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Star Equity Holdings Inc disclosed drop in Revenue from the fourth quarter by -11.85% to $ 50.06 millions, from $ 56.79 millions achived in the previous reporting period.

But that's not important problem, as Star Equity Holdings Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 112 other companies have achieved higher Revenue quarter on quarter growth. While Star Equity Holdings Inc 's Revenue growth quarter on quarter, overall rank is 2619.


Star Equity Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 178.52 $ 141.38 $ 101.69 $ 67.39 $ 57.17
Y / Y Revenue Growth (TTM) 212.29 % 164.97 % 101.86 % 42.94 % 34.33 %
Year on Year Revenue Growth Overall Ranking # 147 # 757 # 3106 # 3174 # 2795
Seqeuential Revenue Change (TTM) 26.27 % 39.04 % 50.89 % 17.89 % 7.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 1281 # 280 # 924 # 734 # 3267


Cumulative Revenue growth Comment
Star Equity Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 212.29% year on year, to $ 179 millions if the fiscal year would have ended in Mar 31 2026.
Star Equity Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 21.84% and higher than 164.97% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 26.27 % from $141.38 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at31.62%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 26.27 % increase from $141.38 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 147, from total ranking in previous quarter at 757.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 71
Healthcare Sector # 50
Overall # 147

Revenue TTM Y/Y Growth Statistics
High Average Low
266.13 %
21.84 %
-74.12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 71
Sector # 204
S&P 500 # 1281
Cumulative Revenue growth Comment
Star Equity Holdings Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 212.29% year on year, to $ 179 millions if the fiscal year would have ended in Mar 31 2026.
Star Equity Holdings Inc 's trailing twelve months Revenue growth was higher than company's average 21.84% and higher than 164.97% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 26.27 % from $141.38 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at31.62%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 26.27 % increase from $141.38 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 49 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 147, from total ranking in previous quarter at 757.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 71
Healthcare Sector # 50
Overall # 147

Revenue TTM Y/Y Growth Statistics
High Average Low
266.13 %
21.84 %
-74.12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 71
Sector # 204
S&P 500 # 1281




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
STRR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Dar Bioscience Inc 499.58%$ 499.579 millions
Scienture Holdings Inc 449.08%$ 449.084 millions
Surrozen Inc 408.65%$ 408.647 millions
Harvard Apparatus Regenerative Technology Inc 402.22%$ 402.222 millions
Nakamoto Inc 362.00%$ 361.999 millions
Vireo Growth Inc.333.47%$ 333.469 millions
Xilio Therapeutics Inc 331.67%$ 331.672 millions
Beam Therapeutics Inc 324.87%$ 324.873 millions
Wave Life Sciences Ltd 316.85%$ 316.850 millions
Insmed Inc301.22%$ 301.215 millions
Volitionrx Limited299.81%$ 299.812 millions
Star Equity Holdings Inc 287.35%$ 287.349 millions
Moderna Inc 260.19%$ 260.185 millions
Omniab Inc 247.30%$ 247.304 millions
Protalix Biotherapeutics inc 233.73%$ 233.729 millions
Pavmed Inc 225.00%$ 225.000 millions
Syndax Pharmaceuticals Inc 223.64%$ 223.640 millions
Catheter Precision Inc 202.10%$ 202.098 millions
Silence Therapeutics Plc197.18%$ 197.183 millions
Autolus Therapeutics Plc191.89%$ 191.895 millions
Co diagnostics Inc 190.30%$ 190.300 millions
Renovorx Inc 185.79%$ 185.787 millions
Cardio Diagnostics Holdings Inc 185.11%$ 185.106 millions
Ars Pharmaceuticals Inc 184.47%$ 184.473 millions
Tonix Pharmaceuticals Holding Corp 183.16%$ 183.162 millions
Dyadic International Inc 182.28%$ 182.275 millions
Nuo Therapeutics Inc 168.82%$ 168.820 millions
Immunitybio inc 167.64%$ 167.639 millions
Allogene Therapeutics Inc 166.67%$ 166.667 millions
Ironwood Pharmaceuticals inc 158.87%$ 158.868 millions


About Star Equity Holdings Inc Revenue Growth Rates (STRR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Star Equity Holdings Inc (CIK 707388).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000707388-25-000113
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Star Equity Holdings Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.